[go: up one dir, main page]

ES2071143T3 - Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270. - Google Patents

Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.

Info

Publication number
ES2071143T3
ES2071143T3 ES91103055T ES91103055T ES2071143T3 ES 2071143 T3 ES2071143 T3 ES 2071143T3 ES 91103055 T ES91103055 T ES 91103055T ES 91103055 T ES91103055 T ES 91103055T ES 2071143 T3 ES2071143 T3 ES 2071143T3
Authority
ES
Spain
Prior art keywords
antibiotic
factors
medicaments
directed
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91103055T
Other languages
English (en)
Inventor
Enrico Selva
Paolo Tavecchia
Ermenegildo Restelli
Pietro Ferrari
Maurizio Denaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2071143T3 publication Critical patent/ES2071143T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

LA INVENCION SE DIRIGE A NUEVAS SUSTANCIAS ANTIBIOTICAS DENOMINADAS ANTIBIOTICO GE 2270 FACTORES B SUB 1, B SUB 2, C SUB 1, C SUB 2, D SUB 1, D SUB 2, E Y T, SUS SALES DE ADICION, SUS COMPOSICIONES FARMACEUTICAS Y SU USO COMO MEDICAMENTOS, ESPECIALMENTE EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS QUE CAUSADAS POR MICROORGANISMOS SUSCEPTIBLES A ELLOS.
ES91103055T 1990-03-08 1991-03-01 Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270. Expired - Lifetime ES2071143T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90104409 1990-03-08
EP90120214 1990-10-22

Publications (1)

Publication Number Publication Date
ES2071143T3 true ES2071143T3 (es) 1995-06-16

Family

ID=26125004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91103055T Expired - Lifetime ES2071143T3 (es) 1990-03-08 1991-03-01 Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.

Country Status (11)

Country Link
US (2) US5747295A (es)
EP (1) EP0451486B1 (es)
JP (1) JP3107584B2 (es)
KR (1) KR0165684B1 (es)
AT (1) ATE121459T1 (es)
CA (1) CA2037779C (es)
DE (1) DE69108972T2 (es)
DK (1) DK0451486T3 (es)
ES (1) ES2071143T3 (es)
GR (1) GR3015899T3 (es)
IE (1) IE67973B1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE163428T1 (de) * 1991-08-30 1998-03-15 Biosearch Italia Spa Faktor c2a des antibiotikums ce 2270
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
AU3805295A (en) * 1994-11-08 1996-05-31 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d2
EP0808326B1 (en) * 1995-02-07 2001-09-12 Biosearch Italia S.p.A. Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
KR100381688B1 (ko) * 1995-02-07 2003-12-11 바이오써치 이탈리아 에스.피.에이. Ge2270및ge2270-유사항생제의염기성프롤린-아미드유도체
US6008225A (en) * 1996-02-14 1999-12-28 Biosearch Italia, S.P.A. Derivatives of antibiotic GE2270 factors C2a, D2 and E
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
PE20080103A1 (es) * 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
CN101563353B (zh) * 2006-12-20 2012-06-27 诺瓦提斯公司 氨基噻唑大环类、它们作为抗菌化合物的用途以及制备它们的方法
US8476224B2 (en) * 2007-06-04 2013-07-02 Novartis Ag Macrocycles and their uses
BRPI0821138A2 (pt) 2007-12-12 2015-06-16 Novatis Ag Aminotiazóis e seus usos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399247A1 (fr) * 1977-08-04 1979-03-02 Rhone Poulenc Ind Antibiotique 35665 rp, sa preparation et les compositions qui les contiennent
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ATE117724T1 (de) * 1989-07-04 1995-02-15 Lepetit Spa Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
ATE163428T1 (de) * 1991-08-30 1998-03-15 Biosearch Italia Spa Faktor c2a des antibiotikums ce 2270
US6008225A (en) * 1996-02-14 1999-12-28 Biosearch Italia, S.P.A. Derivatives of antibiotic GE2270 factors C2a, D2 and E

Also Published As

Publication number Publication date
DE69108972T2 (de) 1995-10-19
JP3107584B2 (ja) 2000-11-13
KR0165684B1 (ko) 1999-01-15
KR910016938A (ko) 1991-11-05
EP0451486A1 (en) 1991-10-16
ATE121459T1 (de) 1995-05-15
DE69108972D1 (de) 1995-05-24
US5747295A (en) 1998-05-05
IE67973B1 (en) 1996-05-15
IE910754A1 (en) 1991-09-11
US5843890A (en) 1998-12-01
EP0451486B1 (en) 1995-04-19
DK0451486T3 (da) 1995-05-08
GR3015899T3 (en) 1995-07-31
CA2037779A1 (en) 1991-09-09
CA2037779C (en) 2002-11-05
JPH04217988A (ja) 1992-08-07

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
FR2679906B1 (fr) Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ES2071143T3 (es) Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
ES2111616T3 (es) Compuestos de ciclohexapeptidil bisamina.
DE69016284D1 (de) Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
ES2098455T3 (es) Compuestos de ciclohexapeptidil propanolamina.
DK0529410T3 (da) Antibiotikum GE 2270 faktor C2a
ATE163294T1 (de) Die antibiotika ge 37468 a, b und c
DE69004941D1 (de) Arzneimittelformulierungen zum Erhöhen der Wirksamkeit von Betalaktamantibiotika in Prophylaxe und Behandlung von infektiöser Krankheit infolge pathogener Bakterien.
EP0359062A3 (en) Antibiotic ge 2270
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
DE69107083D1 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
FI900379A7 (fi) Uudet farmaseuttiset seokset ja uudet farmaseuttiset tuotteet, jotka sallivat leukosyyttien regeneroimisen ja niiden käyttö AIDS:in hoidossa

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451486

Country of ref document: ES